News & Updates

Healthy lifestyle behaviours protective against breast cancer in postmenopausal women

13 Jun 2025

Postmenopausal women who engage in healthy lifestyle behaviours appear to have a reduced risk of breast cancer, regardless of race and ethnicity and hormone receptor status, according to a study.

Healthy lifestyle behaviours protective against breast cancer in postmenopausal women

13 Jun 2025

PFS, OS in unresectable HCC prolonged with anlotinib plus penpulimab

12 Jun 2025

In the treatment of patients with unresectable hepatocellular carcinoma (HCC), anlotinib plus pepulimab appears to significantly increase progression-free survival (PFS) and overall survival (OS) compared with sorafenib, as shown in the results of the phase III APOLLO study conducted in China.

PFS, OS in unresectable HCC prolonged with anlotinib plus penpulimab

12 Jun 2025

Low-carb, animal fat/protein-heavy diet poses increased bladder cancer risk

12 Jun 2025 by

A low-carbohydrate diet (LCD), particularly when its fat and protein sources are predominantly animal-based, may contribute to increased risk of bladder cancer among Chinese Singaporeans, according to new research.

Low-carb, animal fat/protein-heavy diet poses increased bladder cancer risk

12 Jun 2025

Timely rectal cancer treatment extends survival outcomes

12 Jun 2025

The timing of rectal cancer treatment is crucial in improving patient survival, according to a study.

Timely rectal cancer treatment extends survival outcomes

12 Jun 2025

SHR-A1811 shows promise vs HER2-positive breast cancer

12 Jun 2025 by

The third-generation human epidermal growth factor receptor 2 (HER2)-directed antibody‒drug conjugate (ADC) SHR-A1811 has passed its phase II trial, demonstrating safety and efficacy in the neoadjuvant setting for patients with HER2-positive breast cancer.

SHR-A1811 shows promise vs HER2-positive breast cancer

12 Jun 2025

$CAR T-cell therapy offers survival benefits in refractory B-cell ALL$

CAR T-cell therapy offers survival benefits in refractory B-cell ALL

12 Jun 2025

Chimeric antigen receptor (CAR) T-cell therapy in patients with relapsed/refractory B-cell acute lymphoblastic leukaemia (r/r B-ALL) demonstrates efficacy with high rates of durable remissions, as shown in a recent meta-analysis.

CAR T-cell therapy offers survival benefits in refractory B-cell ALL

12 Jun 2025

First-line osimertinib plus chemotherapy further extends PFS in advanced EGFR-mutated NSCLC

12 Jun 2025 by

The third-generation EGFR tyrosine kinase inhibitor (TKI), osimertinib, is preferred over earlier-generation EGFR TKIs as the first-line agent in patients with advanced EGFR-mutated non-small cell lung cancer (NSCLC). In an interview with MIMS Oncology, Dr James Ho, Specialist in Respiratory Medicine in Hong Kong, discussed the positive survival outcomes associated with first-line treatment with osimertinib plus chemotherapy together in patients with advanced EGFR-mutated NSCLC, and shared which patients may benefit from this upfront combination treatment strategy.

First-line osimertinib plus chemotherapy further extends PFS in advanced EGFR-mutated NSCLC

12 Jun 2025

Half of breast cancer survivors experienced substantial psychological distress during COVID-19

11 Jun 2025 by

Half of breast cancer survivors in Hong Kong who recently received the diagnosis experienced a moderate-to-severe level of psychological distress during the COVID-19 pandemic, a cross-sectional study has shown.

Half of breast cancer survivors experienced substantial psychological distress during COVID-19

11 Jun 2025

Innovative biodegradable biohybrid targeted therapy for intracranial tumours

11 Jun 2025 by

The world’s first magnetically driven nonimmunogenic blood hydrogel fibre robot for treatment of deep-seated brain tumours have been successfully developed by a collaborative research team from the Chinese University of Hong Kong (CUHK), the Shenzhen University and the Shenzhen Institutes of Advanced Technology (SIAT).

Innovative biodegradable biohybrid targeted therapy for intracranial tumours

11 Jun 2025

Long-term rectal cancer outcomes better with laparoscopic vs robotic surgery

10 Jun 2025 by

Three-year data from the REAL study has shown that robot-assisted resection of middle or low rectal cancer is associated with lower locoregional recurrence and disease-free survival compared with the conventional laparoscopic approach.

Long-term rectal cancer outcomes better with laparoscopic vs robotic surgery

10 Jun 2025

News & Updates

Filter by Specialty:

Specialty:

Healthy lifestyle behaviours protective against breast cancer in postmenopausal women

Healthy lifestyle behaviours protective against breast cancer in postmenopausal women

PFS, OS in unresectable HCC prolonged with anlotinib plus penpulimab

PFS, OS in unresectable HCC prolonged with anlotinib plus penpulimab

Low-carb, animal fat/protein-heavy diet poses increased bladder cancer risk

Low-carb, animal fat/protein-heavy diet poses increased bladder cancer risk

Timely rectal cancer treatment extends survival outcomes

Timely rectal cancer treatment extends survival outcomes

SHR-A1811 shows promise vs HER2-positive breast cancer

SHR-A1811 shows promise vs HER2-positive breast cancer

CAR T-cell therapy offers survival benefits in refractory B-cell ALL

CAR T-cell therapy offers survival benefits in refractory B-cell ALL

First-line osimertinib plus chemotherapy further extends PFS in advanced EGFR-mutated NSCLC

First-line osimertinib plus chemotherapy further extends PFS in advanced EGFR-mutated NSCLC

Half of breast cancer survivors experienced substantial psychological distress during COVID-19

Half of breast cancer survivors experienced substantial psychological distress during COVID-19

Innovative biodegradable biohybrid targeted therapy for intracranial tumours

Innovative biodegradable biohybrid targeted therapy for intracranial tumours

Long-term rectal cancer outcomes better with laparoscopic vs robotic surgery

Long-term rectal cancer outcomes better with laparoscopic vs robotic surgery